Alpha DNA Investment Management’s Elastic ESTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-13,737
Closed -$1.22M – 134
2022
Q1
$1.22M Buy
+13,737
New +$1.23M 0.86% 56
2021
Q3
– Sell
-9,194
Closed -$1.34M – 118
2021
Q2
$1.34M Buy
9,194
+3,033
+49% +$379K 0.91% 83
2021
Q1
$684K Buy
6,161
+2,888
+88% +$410K 0.79% 40
2020
Q4
$478K Buy
+3,273
New +$402K 0.51% 91

Other funds holding ESTC

Alpha DNA Investment Management's ESTC Position: Q2 2022 in Review

Alpha DNA Investment Management sold out of Elastic (ESTC) in Q2 2022, closing a stake of 13,737 shares — an estimated $1.22M sold.

Alpha DNA Investment Management first reported a position in ESTC in Q4 2020 and held it in 4 quarters. The position peaked at $1.34M in Q2 2021. 335 funds tracked by Wall St. Rank hold ESTC as of Q2 2022.

  • Alpha DNA Investment Management reported no remaining Elastic position as of Q2 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 13,737 Elastic shares in Q2 2022, an estimated $1.22M.
  • Alpha DNA Investment Management first reported a position in Elastic in Q4 2020 and held it in 4 quarters.
  • Alpha DNA Investment Management's Elastic position peaked at $1.34M in Q2 2021.
  • 335 funds tracked by Wall St. Rank held Elastic as of Q2 2022.

Based on Alpha DNA Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.